Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Natural Health Farm Holdings Inc. (NHEL)
Rawang, MY
Natural Health Farm Holdings Inc. (NHEL) is a biotechnology firm currently in its developmental phase, concentrating its efforts on creating a healthcare system rooted in natural and naturopathic remedies. The company, originally incorporated as Amber Group, Inc., officially adopted the name Natural Health Farm Holdings Inc. in March 2017. Established in 2014, its primary operations are based in Rawang, Malaysia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +9,900.00% | -93.33% | -99.95% | -99.95% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Medical - Healthcare Information Services: +14.2%— Q2'19: +6,762.9% (vs Q2'18)
-
EPS growth Medical - Healthcare Information Services: +43.1%-1,116.7% Q2'19: +110.9% (vs Q2'18)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%-1,450.7% Q2'19: -63.3% (vs Q2'18)
-
EBIT margin Medical - Healthcare Information Services: +8.8%-1,759.4% Q2'19: +14.6% (vs Q2'18)
-
ROIC Medical - Healthcare Information Services: +5.2%— Q2'19: +23.2% (vs Q2'18)
-
Share dilution Medical - Healthcare Information Services: -0.1%+3.0% Q2'19: +3.9% (vs Q2'18)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×-0.04× Q2'19: 1.02× (vs Q2'18)
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chuen Meng Tee | President, Chief Executive Officer, Chief Financial Officer, Treasurer & Director | — | male |
| Patricia Yeoh Sin Tze | Company Secretary, Investor Relations Officer & Director | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NHEL
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
